News

Mylan gets US approval for copy version of Astellas’ immunosuppressant Prograf; Teva files complaint over Copaxone patents

22-09-2010

US generic drug major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has received…

Astellas PharmaCopaxoneGenericsImmunologicalsMetabolicsMylan LaboratoriesNorth AmericaPatentsPrografRegulationTeva Pharmaceutical Industries

Back to top